
il-2A
geneN
expressionN
andCC
nf-kappaN
bPCT
activationN
throughP
cd28N
requireV
reactiveA
oxygenN
productionN
byP
5-lipoxygenaseN
.PCT
ofP
theDT
cd28A
surfaceN
receptorN
provideV
aDT
majorA
costimulatoryA
signalN
forP
tN
cellN
resultV
inP
enhancedA
interleukin-2N
(PCT
il-2N
)PCT
proliferationN
primaryA
lymphocyteN
wePP
showV
thatP
ligationN
leadV
toP
rapidA
intracellularA
formationN
intermediateN
roisN
whichDT
beV
cd28-mediatedA
b/N
cd28-responsiveA
complexN
delineationN
signalV
cascadeN
findV
involveV
proteinN
tyrosineN
kinaseN
activityN
,PCT
followV
phospholipaseN
a2N
ourPP
datumN
suggestV
lipoxygenaseN
metaboliteN
activateV
roiN
thenR
induceV
viaP
theseDT
findingN
shouldV
usefulA
therapeuticA
strategyN
developmentN
immunosuppressantsN
targetV
pathwayN
peri-kappaN
siteN
mediateV
humanA
immunodeficiencyN
virusN
typeN
2NUM
enhancerN
monocyteN
butCC
notR
hiv-2N
likeP
hiv-1N
causeV
aidN
associateV
withP
caseN
primarilyR
westA
africaN
hiv-1A
hiv-2A
displayN
significantA
differenceN
nucleicA
acidA
sequenceN
naturalA
historyN
clinicalA
diseaseN
consistentA
haveV
previouslyR
demonstrateV
enhancer/A
promoterN
regionN
functionN
quiteR
differentlyR
fromP
whereasP
T-cellN
stimulationN
largelyR
bindV
transcriptionN
factorN
twoNUM
adjacentA
kappaN
longA
terminalN
repeatN
dependentA
onP
fourNUM
cis-actingA
elementN
:PCT
singleA
purine-richA
bindingA
pub1A
pub2A
petN
nowR
identifyV
novelA
withinP
immediatelyR
upstreamR
designateV
peri-kappaR
thisDT
conserveV
amongP
isolateN
closelyR
relateV
simianA
transfectionN
assayN
monocyticA
lineN
firstA
descriptionN
anDT
displayV
suchA
specificityN
noDT
comparableA
clearlyR
defineV
whileP
nuclearA
SN
bothDT
peripheralA
bloodN
electrophoreticA
mobilityN
shiftN
eitherR
differentA
bindN
versusCC
orCC
recognizeV
undergoV
differentialA
modificationN
thusR
supportV
furtherR
specificA
constitutiveA
seeV
phorbolN
esterN
additionalA
understandV
monocyte-specificA
mayV
ultimatelyR
insightN
intoP
roleN
playV
hivN
pathogenesisN
e1aN
susceptibilityN
killV
nkA
immortalizationN
adenovirusN
infectionN
adN
useV
modelN
changeN
killingN
transientA
vsN
stableA
onlyR
stablyR
transfectedA
targetN
exhibitV
cytolyticA
despiteP
equivalentA
levelN
ad-infectedA
inabilityN
productN
duringP
explainV
inhibitoryA
effectN
viralA
otherwiseR
susceptibleA
classN
iN
mhcN
antigenN
phenotypeN
infectedA
nkN
effectiveA
immunologicA
barrierN
againstP
vivoA
survivalN
neoplasticA
progressionN
e1a-immortalizedA
thatDT
emergeV
reservoirN
persistentlyR
infectV
hostN
distinctA
propertyN
functionallyR
cd4N
epitopesN
cd4A
coreceptorN
interactV
non-polymorphicA
histocompatibilityN
complexA
iiN
moleculeN
antigen-presentingN
contributeV
investigateV
triggerV
lymphomaN
monoclonalN
antibodyN
mabN
deliverV
capableA
nf-atN
interleukin-2A
anti-cd4A
gp120N
couldV
allR
p56lckN
p59fynN
phosphorylationN
shcN
adaptorN
rasN
theyPP
differV
significantlyR
theirPP
abilityN
lackN
fullA
correlateV
dramaticallyR
reduceV
capacityN
calciumN
fluxN
complementV
ionophoreN
resultN
ras/A
cPCT
ligand-dependentA
repressionN
erythroidA
gata-1N
estrogenN
high-doseN
administrationN
anemiaN
mammalN
chickenN
stimulateV
outgrowthN
boneN
marrow-derivedA
progenitorN
delayV
maturationN
delayN
down-regulationN
manyA
cell-specificA
includeV
alpha-N
beta-globinN
bandN
3NUM
@card@NUM
histoneN
h5N
hereR
alsoR
numberN
marrowN
cultureN
addressV
potentialA
mechanismN
suppressV
erythropoiesisN
examineV
participateV
regulationN
majorityN
necessaryA
erythrocyteN
transcriptionalA
stronglyR
repressV
erN
mannerN
reversibleA
presenceN
4-hydroxytamoxifenA
er-mediatedA
gata-1A
occurV
artificialA
containV
gata-bindingN
asR
wellR
asP
contextN
intactA
normallyR
regulateV
erA
eachDT
otherA
vitroN
absenceN
dnaN
coimmunoprecipitationN
experimentN
cosN
associateN
mappingN
indicateV
formN
atP
leastA
contactN
fingerN
n-terminalA
domainN
speculateV
exertV
modulateV
protein-proteinN
interactionN
abstractA
truncateV
wordN
mouseN
alphaN
interleukin-1A
controlN
il-1A
il-2rN
cd4-cd8-N
murineA
precursorN
mapV
interleukinN
responsivenessN
thymicA
lymphoma-derivedA
hybridomaN
pc60N
responseN
il-1N
+PCT
biphasicA
synthesis-independentN
appearanceN
mrnaN
blockV
inhibitorN
itPP
primeV
becomeV
responsiveA
therebyR
prepareV
secondA
phaseN
100-foldN
furtherA
increaseN
transcriptN
severalA
promoter-proximalA
mostR
importantlyR
handN
dependV
78-nucleotideN
segmentN
kilobasesN
startN
il-2-inducibleA
lieV
dnaseN
hypersensitiveA
normalA
threeNUM
statN
hematopoieticA
lineageN
commitmentN
reviewN
focusV
briefA
introductionN
asymmetricA
divisionN
discussionN
methodN
importantA
specifyV
nextA
presentV
useN
embryonicA
stemN
analysisN
targetedA
disruptionN
analyzeV
hematopoiesiN
finallyR
statusN
currentA
knowledgeN
concernV
myeloidA
lymphoidA
summarizeV
epstein-barrA
replicativeA
deN
NovoN
thymocytesN
simultaneousA
earlyA
bzlf-1N
itsPP
repressorN
razN
ebvN
knowV
bN
epithelialA
otherN
canV
subsetN
accompanyV
linearA
genomeN
8NUM
hrN
circularizationN
detectV
contrastN
whereR
circularizeV
bamhiN
zlf-1A
zebraN
rt-pcrN
observeV
fusionN
RazN
compriseV
bzlf-1A
locusN
brlf-1A
immunoprecipitationN
additionN
ebna-1A
transcribeV
fpN
ratherR
thanP
cp/A
wpN
latentlyR
encodeV
gp350/N
coatN
doV
anyDT
evidenceN
lmp-2aN
eber-1A
observationN
mainA
everR
remainV
configurationN
identificationN
purificationN
keyA
cytokineN
immuneA
variousA
chainN
transcriptionallyR
turnN
secreteV
serveV
differentiationN
recentA
studyN
implicateV
jakN
leadN
setV
outP
similarA
transformV
termV
ytN
purifyV
principalA
componentN
bearV
relatednessN
prolactin-inducedA
firstR
sheepN
mammaryA
glandN
tissueN
hypothesizeV
hstat5N
helpV
governV
biologicalA
e2f-1A
cyclin-likeA
repairN
enzymeN
uracil-dnaN
glycosylaseN
autoregulatoryN
cycle-dependentN
speciesN
udgN
osteosarcomaN
saos-2N
deletionN
e2f-1N
e2fN
putativeA
downstreamA
locateV
exonN
e2f-1/A
dp1A
functionalA
relationshipN
betweenP
highA
e2f-mediatedA
overexpressionN
saosN
growthN
lateR
g1A
transientlyR
arrestV
progressV
sA
hypotheticalA
integrateV
oneNUM
cycleN
likelyR
multifunctionalA
possiblyR
damageN
negativeA
cellularA
molecularA
ifn-gammaN
il-12N
interferon-gammaN
immunoregulatoryN
produceV
predominantlyR
largeA
granularA
lglN
extracellularA
particularA
interleukinsN
ilsN
potentA
inducerN
althoughP
reportV
thereP
someDT
yetR
reportN
killerN
respondV
nk3.3N
deriveV
measureV
granulocyte-macrophageN
colony-stimulatingN
gm-csfN
cytoplasmicA
whenR
togetherR
il-12A
synergizedN
inductionN
synergyN
attributeV
increaseV
accumulationN
stabilityN
mrnasN
fiveNUM
cyclosporinN
csaN
factor-betaN
cycloheximideN
genisteinN
staurosporineN
nk3.3A
newA
synthesisN
appearV
partiallyR
furthermoreR
generallyR
inactiveA
suppressionN
cytokineA
agentN
independentA
inhibitionN
ap1A
dissectV
biochemicalA
eventN
p95vavN
tcrN
multipleA
numerousA
substrateN
expressV
exclusivelyR
trophoblastN
structuralA
motifN
srcN
homologyN
pleckstrinN
guanineN
nucleotideN
exchangeN
tcr-mediatedA
processN
unclearA
aloneR
jurkatN
nfatN
synergizesN
nfat-N
interleukin-2-dependentA
g-protein-coupledA
removalN
aminoN
acidN
potentialN
nihN
3t3A
p95vav-inducedA
mimicV
rasA
thoughP
uponP
rafN
fk506N
calcineurinN
involvementN
mutantN
deficientA
functionV
howeverR
influenceV
tcr-inducedA
freeA
takeV
unidentifiedA
proximalA
positionN
positiveA
aml1-relatedA
pebp2N
consensusN
polyomavirusN
binding-proteinN
consistV
betaN
subunitsN
subunitN
homologueN
aml1A
breakpointN
;PCT
leukemiasN
a1N
a-geneN
b1N
B2N
b-encodedA
isomerN
pebp2A
enhanceV
promoter-drivenA
reporterN
plasmidN
unstimulatedA
12-o-tetradecanoylphorbolA
13-acetate/A
phytohemagglutinin-stimulatedA
coexpressionN
determineV
b1/N
ratioN
extractN
site-bindingN
cross-reactedV
antimouseN
A1A
northernA
blotN
betaA
preciseA
presentA
importanceN
relativeA
isoformsN
lps-inducedA
tnfN
augmentV
/PCT
macrophageN
bacterialA
endotoxinN
lipopolysaccharideN
criticalA
highlyR
defenceN
augmentationN
lpsN
interferonN
gammaN
referV
primingN
establishV
poorlyR
tumourN
necrosisN
designV
analyseV
detailN
manifestV
pre-treatmentN
affectV
magnitudeN
sensitivityN
afterP
hourN
treatmentN
stateN
eitherDT
m-csfN
rateN
freshlyR
isolateV
markedA
factor-kappaN
oligonucleotideN
muchR
moreR
unprimedA
t1/N
6-8-foldN
durationN
longerR
greatA
possessV
h-89N
substantiallyR
myc-associatedA
zincN
developmentalA
minimalA
mutagenesisN
initiator-likeA
presentN
capN
EtsA
MazN
predominantA
lastA
resembleV
me1a1A
g3ag4ag3N
p2A
c-mycN
thereforeR
believeV
likelyA
erythropoietinN
tal1/A
sclN
tal1N
originallyR
recurrentA
chromosomalA
translocationN
frequentA
lesionN
acuteA
lymphoblasticA
leukemiaN
basic-helix-loop-helixN
characteristicN
familyN
canonicalA
canntgN
heterodimersN
tal1A
chemical-inducedA
erythroleukemiaN
vivoR
mightV
aspectN
sinceP
terminalA
controlV
glycoproteinN
hormoneN
epoN
whetherP
splenicA
erythroblastN
anemia-inducingN
strainN
friendN
fvaN
elicitV
dose-relatedA
stabilizeV
onePP
epo-inducibleA
extractV
subsequentlyR
decayV
accumulateV
temporallyR
epo-inducedA
actN
posttranscriptionalA
virus-inducedA
linkN
memberN
diverseA
nonradioactiveA
quantificationN
glucocorticoidA
u937A
describeV
baseV
strandN
competitionN
identicalA
biotin-N
fluorescein-labeledA
ampliconN
probeN
unlabeledA
hybridizationN
quantityN
double-labeledA
decreaseV
accordanceN
massA
actionN
lawN
techniqueN
successfullyR
applyV
evaluateV
beforeP
13-acetateA
tpaN
combinationN
all-transN
retinoicA
raN
1,25-dihydroxyvitaminN
d2N
vdN
[PCT
3h]dexamethasoneA
up-regulationN
GrN
perceiveV
vdA
sp1A
b-independentN
okadaicA
purelyR
enhancer-dependentA
cytokinesN
regulatoryA
ltrN
okaN
bothCC
inducibilityN
ltr-drivenA
luciferaseN
constructN
lymphoblastoidA
tataN
boxN
tbpN
intenseA
constitutivelyR
nucleusN
shareV
phaN
deleteV
tatN
selectiveA
serine-threonineA
phosphataseN
pp2aN
facilitateV
generalA
wouldV
independentlyR
lowA
basalA
commonA
generationN
pleiotropyN
redundancyN
il-4A
il-7A
il-13A
il-15N
baseN
compareV
pblsN
sharedA
rapidlyR
stat5N
freshA
pblN
stat3N
preactivatedA
sameA
featureN
existenceN
tyrosine-phosphorylatedA
il-7rN
dockV
il-13N
il-4N
il-4rN
underP
physiologicalA
conditionN
b-alphaN
proteolysisN
site-specificA
signal-inducedA
inhibitV
retainV
cytoplasmN
stimulusN
typicallyR
thoseDT
stressN
pathogenN
inactivateV
liberateV
translocateV
initiateV
defenseN
organismN
serine-32N
serine-36N
mutateV
degradationN
residueN
regulatorN
eporN
constructV
5NUM
'PP
flankV
mostA
bpN
fragmentN
ap2A
erythroid-specificA
heporN
ocim1N
k562N
respectivelyR
reflectV
lackV
protein-dnaN
ccgcccN
non-erythroidA
co-transfectionN
ableA
transactivateV
activeA
ocim1A
interestinglyR
decreaseN
restoreV
transactivationN
coordinationN
sp1-likeA
tissue-specificA
dr-nm23N
nm23A
granulocyteN
apoptosisN
32dc13A
